Dr. Reddy’s Laboratories Revenue: Proven Growth in Q2 FY27
Dr. Reddy’s Laboratories revenue shows a significant rise in Q2 FY27, reaching ₹8,671 crore, indicating strong performance.
Dr. Reddy’s Laboratories revenue shows a significant rise in Q2 FY27, reaching ₹8,671 crore, indicating strong performance.
D. E. Shaw India office expansion marks a milestone with 6 lakh square feet at Neopolis, enhancing business prospects.